NEW YORK (GenomeWeb News) – Intrexon's shares were up as much as 69 percent on its first day of trading on the New York Stock Exchange today.
In afternoon trading, shares of the Germantown, Md.-based synthetic biology firm remained sharply up at 50 percent at $24.05.
It had priced its initial public offering of nearly 10 million shares at $16 per share, the upper end of an earlier anticipated price range. Intrexon also has granted underwriters a 30-day option to buy up to about 1.5 million additional shares of the company's stock. JP Morgan and Barclays are the joint book-running agents on the offering.
Intrexon's shares trade under ticker symbol "XON". The company filed to go public in early July.